Drug developers of orphan drugs face unique challenges. Minimising uncertainty for biopharmaceutical payers & manufacturers is key in maximising opportunity in pricing & access of orphan drugs.
In this webinar, we’ll discuss some of the key issues in pricing & access of orphan drugs. We’ll also demonstrate how GPI horizon methodology can be applied to forecast prices & payer-perceived value of an asset within a variety of scenarios.